Harriet Kang
Neurology · Hartsdale, NYNPI 1235192683
Payments from drug & device makers
Across 132 payments — averaging $2672.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB SA$140K
- Aquestive Therapeutics, Inc.$117K
- Zogenix Inc.$41K
- Eisai Inc.$39K
- Neurelis, Inc.$12K
- Greenwich Biosciences, Inc.$674
- plus $3K from 20 others
Across 9 payments — averaging $662.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB, Inc.$4K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
What the payments were for
- Consulting fees$7,20065%
- Food & beverage$3,89835%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB SA | 15 | $140,431 |
| Aquestive Therapeutics, Inc. | 17 | $117,092 |
| Zogenix Inc. | 5 | $40,867 |
| Eisai Inc. | 7 | $39,130 |
| Neurelis, Inc. | 11 | $12,056 |
| Greenwich Biosciences, Inc. | 7 | $674 |
| Jazz Pharmaceuticals Inc. | 19 | $655 |
| Immedica Pharma US, Inc. | 10 | $416 |
| UCB, Inc. | 7 | $401 |
| SK Life Science, Inc. | 6 | $229 |
| Sunovion Pharmaceuticals Inc. | 4 | $221 |
| Biocodex, Inc. | 2 | $102 |
| Monteris Medical Corporation | 2 | $98 |
| Ironshore Pharmaceuticals Inc. | 4 | $80 |
| Livanova USA, Inc. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $46 |
| Zimmer Biomet | 1 | $36 |
| Tris Pharma Inc | 2 | $35 |
| Neuropace, Inc. | 1 | $34 |
| Aucta Pharmaceuticals, Inc. | 3 | $26 |
| Vertical Pharmaceuticals, LLC | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Catalyst Pharmaceuticals, Inc. | 1 | $19 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$352,803 in reported general payments places this provider in the 90th percentile of 1,623 neurology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Zonisamide | 13 | $255 |
| Clobazam | 11 | $251 |
Paid to pharmacies, not to this prescriber.
Other neurology in Hartsdale
- Christian GrommesNew York$9.9M
- Ilya KisterNew York$9.5M
- E DorseyNew York$8.5M
- Lauren SchaffNew York$8.2M
- Richard HolubAlbany$6.3M
- Martin SadowskiNew York$5.4M
- Lawrence HonigNew York$4.9M
- Laszlo MechtlerAmherst$4.3M
- Bennett MyersAmherst$3.8M
- Krupa PandeyAlbany$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.